Abstract
Aims: Liver fibrogenesis is accompanied by angiogenesis, but the pro- and anti-angiogenic factors in this setting are not well characterized. While the vascular endothelial growth factor (VEGF) plays an important role in the induction of physiological and pathological angiogenesis in various tissues, the ELR- chemokines which are ligands for the receptor CXCR3 are known to inhibit angiogenesis. Recently, we could show that CXCR3–/– mice display progressive liver fibrosis compared to wild-type littermates after chronic CCl4 and TAA treatment. We here investigate the role of neovascularisation in CCl4-treated CXCR3–/– and wild-type mice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
